JESSICA FORTUNAK: Open Payments
NPI 1316122484 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$127 in 6 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $176 · 2025 $127
Food & beverage: $127
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $44 |
| Astellas Pharma US Inc | 1 | $24 |
| Novo Nordisk Inc | 1 | $23 |
| ABBVIE INC. | 1 | $21 |
| Lundbeck LLC | 1 | $15 |
Products named: MOUNJARO, Veozah, Ozempic, VRAYLAR, REXULTI.
Industry payments across IN — which companies pay providers there.
